Literature DB >> 15265807

Triazine dyes are agonists of the NAADP receptor.

Richard A Billington1, Judit Bak, Ana Martinez-Coscolla, Marcella Debidda, Armando A Genazzani.   

Abstract

NAADP has been shown to be a potent calcium-releasing second messenger in a wide variety of cell types to date. However, research has been hampered by a lack of pharmacological agents, with which to investigate NAADP-induced calcium release, and by the molecular identity of its cellular target protein being unknown. In the present paper, the sea urchin egg model was used to investigate whether triazine dyes, which can act as nucleotide mimetics, can bind to the NAADP receptor, induce Ca(2+) release and be used for affinity chromatography of the receptor. Indeed, all the triazine dyes tested (Reactive Red 120 (RR120), Reactive Green 19 (RG19), Reactive Green 5 (RG5), Cibacron Blue 3GA and Reactive Yellow 86) displayed micromolar affinities, except for Reactive Orange 14. Furthermore, unlike NAADP, RR120, RG19 and RG5 did not bind in an irreversible manner. The compound that displayed the highest affinity, RR120, was tested in a (45)Ca(2+) efflux assay. This compound released Ca(2+) via the NAADP receptor, as shown by the ability of subthreshold NAADP concentrations to inhibit this release. Furthermore, heparin and ruthenium red were unable to block RR120-induced Ca(2+) release. We have also shown that RG5 and RG19, immobilised on resins, retain the ability to bind to the receptor, and that this interaction can be disrupted by high salt concentrations. As a proof of principle, we have shown that this can be used to partially purify the NAADP receptor by at least 75-fold. In conclusion, triazine dyes interact with the NAADP receptor, and this could be exploited in future to create a new generation of pharmacological tools to investigate this messenger and, in combination with other techniques, to purify the receptor.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15265807      PMCID: PMC1575193          DOI: 10.1038/sj.bjp.0705886

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  25 in total

1.  Unique kinetics of nicotinic acid-adenine dinucleotide phosphate (NAADP) binding enhance the sensitivity of NAADP receptors for their ligand.

Authors:  S Patel; G C Churchill; A Galione
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

Review 2.  Dye-ligand affinity systems.

Authors:  A Denizli; E Pişkin
Journal:  J Biochem Biophys Methods       Date:  2001-10-30

3.  Reactive blue 2 induces calcium oscillations in HeLa cells.

Authors:  A Okuda; K Furuya; T Kiyohara
Journal:  Jpn J Physiol       Date:  2001-06

Review 4.  Coordination of Ca2+ signalling by NAADP.

Authors:  S Patel; G C Churchill; A Galione
Journal:  Trends Biochem Sci       Date:  2001-08       Impact factor: 13.807

5.  Transformation of local Ca2+ spikes to global Ca2+ transients: the combinatorial roles of multiple Ca2+ releasing messengers.

Authors:  Jose M Cancela; Fabien Van Coppenolle; Antony Galione; Alexei V Tepikin; Ole H Petersen
Journal:  EMBO J       Date:  2002-03-01       Impact factor: 11.598

6.  Characterization of NAADP(+) binding in sea urchin eggs.

Authors:  R A Billington; A A Genazzani
Journal:  Biochem Biophys Res Commun       Date:  2000-09-16       Impact factor: 3.575

Review 7.  NAADP: an atypical Ca2+-release messenger?

Authors:  Armando A Genazzani; Richard A Billington
Journal:  Trends Pharmacol Sci       Date:  2002-04       Impact factor: 14.819

8.  Effect of luminal and extravesicular Ca2+ on NAADP binding and release properties.

Authors:  Judit Bak; Richard A Billington; Armando A Genazzani
Journal:  Biochem Biophys Res Commun       Date:  2002-07-26       Impact factor: 3.575

9.  Nicotinic acid adenine dinucleotide phosphate (NAADP) is present at micromolar concentrations in sea urchin spermatozoa.

Authors:  Richard A Billington; Andrew Ho; Armando A Genazzani
Journal:  J Physiol       Date:  2002-10-01       Impact factor: 5.182

10.  Nicotinic acid adenine dinucleotide phosphate (NAADP(+)) is an essential regulator of T-lymphocyte Ca(2+)-signaling.

Authors:  I Berg; B V Potter; G W Mayr; A H Guse
Journal:  J Cell Biol       Date:  2000-08-07       Impact factor: 10.539

View more
  6 in total

Review 1.  Two-pore channels: Regulation by NAADP and customized roles in triggering calcium signals.

Authors:  Sandip Patel; Jonathan S Marchant; Eugen Brailoiu
Journal:  Cell Calcium       Date:  2010-06       Impact factor: 6.817

2.  The effects of removing the GAT domain from E. coli GMP synthetase.

Authors:  Jessica L Abbott; Jordan M Newell; Christine M Lightcap; Mary E Olanich; Danielle T Loughlin; Melanie A Weller; Gary Lam; Sidney Pollack; Walter A Patton
Journal:  Protein J       Date:  2006-12       Impact factor: 2.371

3.  Small Molecule Antagonists of NAADP-Induced Ca2+ Release in T-Lymphocytes Suggest Potential Therapeutic Agents for Autoimmune Disease.

Authors:  Bo Zhang; Joanna M Watt; Chiara Cordiglieri; Werner Dammermann; Mary F Mahon; Alexander Flügel; Andreas H Guse; Barry V L Potter
Journal:  Sci Rep       Date:  2018-11-13       Impact factor: 4.379

4.  The Molecular Basis for Ca2+ Signalling by NAADP: Two-Pore Channels in a Complex?

Authors:  Jonathan S Marchant; Yaping Lin-Moshier; Timothy F Walseth; Sandip Patel
Journal:  Messenger (Los Angel)       Date:  2012-06-01

5.  Identification of a chemical probe for NAADP by virtual screening.

Authors:  Edmund Naylor; Abdelilah Arredouani; Sridhar R Vasudevan; Alexander M Lewis; Raman Parkesh; Akiko Mizote; Daniel Rosen; Justyn M Thomas; Minoru Izumi; A Ganesan; Antony Galione; Grant C Churchill
Journal:  Nat Chem Biol       Date:  2009-02-22       Impact factor: 15.040

6.  A screening campaign in sea urchin egg homogenate as a platform for discovering modulators of NAADP-dependent Ca2+ signaling in human cells.

Authors:  Gihan S Gunaratne; Malcolm E Johns; Hallie M Hintz; Timothy F Walseth; Jonathan S Marchant
Journal:  Cell Calcium       Date:  2018-08-16       Impact factor: 6.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.